InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Wednesday, 11/30/2022 12:16:28 PM

Wednesday, November 30, 2022 12:16:28 PM

Post# of 462126
It will be interesting to compare ANAVEX 2-73 to Biogens drug. IF THE BENEFITS ARE EQUAL there are significant safety concerns about lecanemab. Two patients have died in their trial from apparent drug related causes. And an infusion every two weeks is a lot costlier and disruptive than taking a 273 pill once a day! That why ANAVEX has a huge safety, cost and delivery advantage.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News